L-Glutathione (reduced GSH) lyophilized intracellular tripeptide antioxidant (γ-Glu-Cys-Gly) for in vitro redox-biology research.
Every batch of L-Glutathione is sent to an accredited independent laboratory before it ships. Here is exactly what we screen for - and the certificate that proves it.
Three converging redox pathways studied in cell-culture and biochemical research models
The free cysteine thiol (-SH) on GSH donates electrons to reactive oxygen species, including hydrogen peroxide and lipid peroxides, generating oxidized glutathione disulfide (GSSG). Glutathione reductase regenerates GSH from GSSG at the expense of NADPH, maintaining the cellular GSH:GSSG ratio that defines redox potential (Lu, 2013).
Glutathione S-transferases (GSTs) catalyze nucleophilic addition of the GSH thiol to electrophilic xenobiotics, drug metabolites, and lipid-derived aldehydes (4-HNE). The resulting GSH-conjugates enter the mercapturate pathway for renal/biliary export, a central Phase II detoxification route (Forman et al., 2009).
GSH integrates with the wider antioxidant network: regenerating ascorbate and α-tocopherol, supporting peroxiredoxin/thioredoxin redox cycles via the Nrf2-driven gene program, and S-glutathionylating protein cysteines as a reversible post-translational redox switch (Aoyama et al., 2008).
Key preclinical findings from peer-reviewed glutathione literature
Primary preclinical areas of L-Glutathione investigation
GSH is the dominant intracellular antioxidant in mammalian cells. Cell-culture models manipulate GSH levels (BSO depletion, exogenous GSH addition) to study ROS-driven apoptosis, ferroptosis, and lipid peroxidation, with the GSH:GSSG ratio serving as the canonical readout of cellular redox state.
Lu 2013 ↗The liver maintains the highest GSH concentrations in the body and is the principal site of GST-mediated Phase II conjugation. Preclinical models use GSH-depletion (acetaminophen, CCl₄) to study drug-induced liver injury, while GSH precursors (NAC, GSH ethyl ester) are studied as rescue agents.
Forman et al. 2009 ↗In vitro and ex vivo melanocyte models report that GSH inhibits tyrosinase activity and shifts melanogenesis from eumelanin toward pheomelanin via thiol-mediated copper chelation, supporting GSH as a research tool compound in melanin-biology and skin-pigmentation cell models.
Sonthalia et al. 2017 ↗Brain GSH depletion is consistently reported in preclinical Parkinson's and Alzheimer's models. Neuronal GSH synthesis (via the EAAC1 cysteine transporter) and dopaminergic neuron vulnerability to oxidative stress are central research questions in cell-based and rodent neurodegeneration models.
Aoyama et al. 2008 ↗Technical specifications and analytical profile
Common questions about L-Glutathione research parameters
Peer-reviewed publications and preclinical studies database